Many adults with obstructive hypertrophic cardiomyopathy (oHCM) taking mavacamten experienced new atrial fibrillation or flutter, new-onset heart failure, and frequent acute care use within months of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback